OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lipoprotein(a) and cardiovascular and valvular diseases: A genetic epidemiological perspective
Benoît J. Arsenault, Pia R. Kamstrup
Atherosclerosis (2022) Vol. 349, pp. 7-16
Closed Access | Times Cited: 83

Showing 1-25 of 83 citing articles:

Lipoprotein(a) measurement issues: Are we making a mountain out of a molehill?
Florian Kronenberg
Atherosclerosis (2022) Vol. 349, pp. 123-135
Open Access | Times Cited: 88

Non-genetic influences on lipoprotein(a) concentrations
Byambaa Enkhmaa, Lars Berglund
Atherosclerosis (2022) Vol. 349, pp. 53-62
Open Access | Times Cited: 86

Lipoprotein(a) and ethnicities
Anurag Mehta, Vardhmaan Jain, Anum Saeed, et al.
Atherosclerosis (2022) Vol. 349, pp. 42-52
Open Access | Times Cited: 70

Frequent questions and responses on the 2022 lipoprotein(a) consensus statement of the European Atherosclerosis Society
Florian Kronenberg, Samia Mora, Erik S.G. Stroes, et al.
Atherosclerosis (2023) Vol. 374, pp. 107-120
Open Access | Times Cited: 58

Recommendations of the Experts of the Polish Cardiac Society (PCS) and the Polish Lipid Association (PoLA) on the diagnosis and management of elevated lipoprotein(a) levels
Bożena Sosnowska, Janina Stępińska, Przemysław Mitkowski, et al.
Archives of Medical Science (2024) Vol. 20, Iss. 1, pp. 8-27
Open Access | Times Cited: 19

High lipoprotein(a): Actionable strategies for risk assessment and mitigation
Gissette Reyes‐Soffer, Calvin Yeang, Erin D. Michos, et al.
American Journal of Preventive Cardiology (2024) Vol. 18, pp. 100651-100651
Open Access | Times Cited: 17

Beyond fibrinolysis: The confounding role of Lp(a) in thrombosis
Michael B. Boffa
Atherosclerosis (2022) Vol. 349, pp. 72-81
Open Access | Times Cited: 60

Lipoprotein(a): An underestimated inflammatory mastermind
Kim E. Dzobo, Jordan M. Kraaijenhof, Erik S.G. Stroes, et al.
Atherosclerosis (2022) Vol. 349, pp. 101-109
Open Access | Times Cited: 58

Lipoprotein (a) and diabetes mellitus
Claudia Lamina, Natalie C. Ward
Atherosclerosis (2022) Vol. 349, pp. 63-71
Open Access | Times Cited: 58

Existing and emerging strategies to lower Lipoprotein(a)
Gregory G. Schwartz, Christie M. Ballantyne
Atherosclerosis (2022) Vol. 349, pp. 110-122
Open Access | Times Cited: 49

Oxidized phospholipid modification of lipoprotein(a): Epidemiology, biochemistry and pathophysiology
Marlys L. Koschinsky, Michael B. Boffa
Atherosclerosis (2022) Vol. 349, pp. 92-100
Open Access | Times Cited: 49

Recent advances in demystifying the metabolism of lipoprotein(a)
Kévin Chemello, Dick C. Chan, Gilles Lambert, et al.
Atherosclerosis (2022) Vol. 349, pp. 82-91
Open Access | Times Cited: 43

Lipoprotein(a) as a Risk Factor for Cardiovascular Diseases: Pathophysiology and Treatment Perspectives
Pierandrea Vinci, Filippo Giorgio Di Girolamo, Emiliano Panizon, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 18, pp. 6721-6721
Open Access | Times Cited: 42

Lipoprotein(a) and Risks of Peripheral Artery Disease, Abdominal Aortic Aneurysm, and Major Adverse Limb Events
P. E. Thomas, Signe Vedel‐Krogh, Sune F. Nielsen, et al.
Journal of the American College of Cardiology (2023) Vol. 82, Iss. 24, pp. 2265-2276
Open Access | Times Cited: 25

Lipoprotein(a): from Causality to Treatment
Florian Kronenberg
Current Atherosclerosis Reports (2024) Vol. 26, Iss. 3, pp. 75-82
Open Access | Times Cited: 15

Lipoprotein(a) and cardiovascular disease: sifting the evidence to guide future research
Pia R. Kamstrup, R. Dermot G. Neely, Steven E. Nissen, et al.
European Journal of Preventive Cardiology (2024) Vol. 31, Iss. 7, pp. 903-914
Open Access | Times Cited: 9

Mendelian Randomization: Principles and its usage in Lp(a) research
Claudia Lamina
Atherosclerosis (2022) Vol. 349, pp. 36-41
Open Access | Times Cited: 30

Lipoprotein(a) and carotid intima-media thickness in children with familial hypercholesterolaemia in the Netherlands: a 20-year follow-up study
Lotte M. de Boer, Albert Wiegman, Jeffrey Kroon, et al.
The Lancet Diabetes & Endocrinology (2023) Vol. 11, Iss. 9, pp. 667-674
Closed Access | Times Cited: 19

Lipoprotein(a) and cardiovascular disease
Michael B. Boffa, Marlys L. Koschinsky
Biochemical Journal (2024) Vol. 481, Iss. 19, pp. 1277-1296
Open Access | Times Cited: 6

Consensus and guidelines on lipoprotein(a) – seeing the forest through the trees
Florian Kronenberg, Samia Mora, Erik S.G. Stroes
Current Opinion in Lipidology (2022) Vol. 33, Iss. 6, pp. 342-352
Open Access | Times Cited: 28

The long journey of lipoprotein(a) from cardiovascular curiosity to therapeutic target
Marlys L. Koschinsky, Florian Kronenberg
Atherosclerosis (2022) Vol. 349, pp. 1-6
Open Access | Times Cited: 26

Relationship of low-density lipoprotein-cholesterol and lipoprotein(a) to cardiovascular risk: The Multi-Ethnic Study of Atherosclerosis (MESA)
Rishi Rikhi, Aziz Hammoud, Nicklaus P. Ashburn, et al.
Atherosclerosis (2022) Vol. 363, pp. 102-108
Open Access | Times Cited: 26

Daring to dream: Targeting lipoprotein(a) as a causal and risk-enhancing factor
Marlys L. Koschinsky, Erik S.G. Stroes, Florian Kronenberg
Pharmacological Research (2023) Vol. 194, pp. 106843-106843
Open Access | Times Cited: 14

Lifestyle and Lipoprotein(a) Levels: Does a Specific Counseling Make Sense?
Federica Fogacci, Valentina Di Micoli, Pierre Sabouret, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 3, pp. 751-751
Open Access | Times Cited: 5

Consensus on lipoprotein(a) of the Spanish Society of Arteriosclerosis. Literature review and recommendations for clinical practice
Javier Delgado‐Lista, José María Mostaza, Teresa Arrobas-Velilla, et al.
Clínica e Investigación en Arteriosclerosis (English Edition) (2024) Vol. 36, Iss. 4, pp. 243-266
Closed Access | Times Cited: 5

Page 1 - Next Page

Scroll to top